{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:22:21Z","timestamp":1789726941109,"version":"4.0.1"},"reference-count":56,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,2,3]]},"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether sickle cell carriers (\u2018sickle cell trait\u2019) have an increased risk of venous thromboembolism (VTE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cohort study with nested case\u2013control analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>General population with data from 609 UK general practices in the Clinical Practice Research Datalink (CPRD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>All individuals registered with a CPRD general practice between 1998 and 2013, with a medical record of screening for sickle cell between 18 and 75\u2005years of age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcomes measures<\/jats:title>\n                    <jats:p>Incidence of VTE per 10\u2005000 person-years (PY) among sickle cell carriers and non-carriers; and adjusted OR for VTE among sickle cell carriers compared with non-carriers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 30\u2005424 individuals screened for sickle cell, with a follow-up time of 179\u2005503 PY, identifying 55 VTEs in 6758 sickle cell carriers and 125 VTEs in 23\u2005666 non-carriers. VTE incidence among sickle cell carriers (14.9\/10\u2005000 PY; 95% CI 11.4 to 19.4) was significantly higher than non-carriers (8.8\/10\u2005000 PY; 95% CI 7.4 to 10.4). Restricting analysis to confirmed non-carriers was non-significant, but performed on a small sample. In the case\u2013control analysis (180 cases matched to 1775 controls by age and gender), sickle cell carriers remained at increased risk of VTE after adjusting for body mass index, pregnancy, smoking status and ethnicity (OR 1.78, 95% CI 1.18 to 2.69, p=0.006), with the greatest risk for pulmonary embolism (PE) (OR 2.27, 95% CI 1.17 to 4.39, p=0.011).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although absolute numbers are small, in a general population screened for sickle cell, carriers have a higher incidence and risk of VTE, particularly PE, than non-carriers. Clinicians should be aware of this elevated risk in the clinical care of sickle cell carriers, or when discussing carrier screening, and explicitly attend to modifiable risk factors for VTE in these individuals. More complete primary care coding of carrier status could improve analysis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-012665","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T20:10:20Z","timestamp":1490904620000},"page":"e012665","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":30,"title":["Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case\u2013control analysis"],"prefix":"10.1136","volume":"7","author":[{"given":"Iain","family":"Little","sequence":"first","affiliation":[{"name":"Division of Primary Care, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Vinogradova","sequence":"additional","affiliation":[{"name":"Division of Primary Care, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Orton","sequence":"additional","affiliation":[{"name":"Division of Primary Care, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Kai","sequence":"additional","affiliation":[{"name":"Division of Primary Care, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Division of Primary Care, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,3,29]]},"reference":[{"key":"2025121408495956000_7.3.e012665.1","doi-asserted-by":"crossref","unstructured":"Serjeant GR , Serjeant BE . Sickle cell disease. 3rd edn . Oxford: Oxford University Press, 2001.","DOI":"10.1046\/j.1365-2141.2001.02557.x"},{"key":"2025121408495956000_7.3.e012665.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.12.020"},{"key":"2025121408495956000_7.3.e012665.3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull World Health Organ"},{"key":"2025121408495956000_7.3.e012665.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2011.09.014"},{"key":"2025121408495956000_7.3.e012665.5","unstructured":"England. PH. NHS Sickle Cell and Thallasaemia programme Fact and Figures. Secondary NHS Sickle Cell and Thallasaemia programme Fact and Figures. http:\/\/sct.screening.nhs.uk\/statistics"},{"key":"2025121408495956000_7.3.e012665.6","first-page":"181","article-title":"Exercise and hemoglobin S","volume":"31","author":"Kark","year":"1994","journal-title":"Semin Hematol"},{"key":"2025121408495956000_7.3.e012665.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198709243171301"},{"key":"2025121408495956000_7.3.e012665.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.804617"},{"key":"2025121408495956000_7.3.e012665.9","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2011-090896"},{"key":"2025121408495956000_7.3.e012665.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197002052820607"},{"key":"2025121408495956000_7.3.e012665.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1007639"},{"key":"2025121408495956000_7.3.e012665.12","doi-asserted-by":"publisher","DOI":"10.1057\/sth.2014.17"},{"key":"2025121408495956000_7.3.e012665.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.15063"},{"key":"2025121408495956000_7.3.e012665.14","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2010.1.418"},{"key":"2025121408495956000_7.3.e012665.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-057604"},{"key":"2025121408495956000_7.3.e012665.16","doi-asserted-by":"publisher","DOI":"10.3109\/03630269.2013.832689"},{"key":"2025121408495956000_7.3.e012665.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2009.01.038"},{"key":"2025121408495956000_7.3.e012665.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197905033001801"},{"key":"2025121408495956000_7.3.e012665.19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064141"},{"key":"2025121408495956000_7.3.e012665.20","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12787"},{"key":"2025121408495956000_7.3.e012665.21","unstructured":"Johnson AG . Report of a working party of the Standing Medical Advisory Committee on sickle cell, thalassaemia and other haemoglobinopathies. London: HMSO, 1993."},{"key":"2025121408495956000_7.3.e012665.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.08054.x"},{"key":"2025121408495956000_7.3.e012665.23","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2009.12.006"},{"key":"2025121408495956000_7.3.e012665.24","unstructured":"NHS Digital. Attribution data set GP-registered populations 2010\u20132012. http:\/\/content.digital.nhs.uk\/pubs\/gpregpop10"},{"key":"2025121408495956000_7.3.e012665.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)04248-7"},{"key":"2025121408495956000_7.3.e012665.26","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/21.3.299"},{"key":"2025121408495956000_7.3.e012665.27","doi-asserted-by":"crossref","unstructured":"Crooks C . The epidemiology of upper gastrointestinal bleeding. University of Nottingham, 2013.","DOI":"10.1002\/9781118727072.ch16"},{"key":"2025121408495956000_7.3.e012665.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03537.x"},{"key":"2025121408495956000_7.3.e012665.29","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00199.x"},{"key":"2025121408495956000_7.3.e012665.30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1098"},{"key":"2025121408495956000_7.3.e012665.31","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-005-0128-8"},{"key":"2025121408495956000_7.3.e012665.32","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.13.1105.38083"},{"key":"2025121408495956000_7.3.e012665.33","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e31819ec966"},{"key":"2025121408495956000_7.3.e012665.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61963-2"},{"key":"2025121408495956000_7.3.e012665.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.10.021"},{"key":"2025121408495956000_7.3.e012665.36","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000046771.12875.6C"},{"key":"2025121408495956000_7.3.e012665.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08956.x"},{"key":"2025121408495956000_7.3.e012665.38","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2007.02.004"},{"key":"2025121408495956000_7.3.e012665.39","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.9.935"},{"key":"2025121408495956000_7.3.e012665.40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001515"},{"key":"2025121408495956000_7.3.e012665.41","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21059"},{"key":"2025121408495956000_7.3.e012665.42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003389"},{"key":"2025121408495956000_7.3.e012665.43","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3537"},{"key":"2025121408495956000_7.3.e012665.44","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2135"},{"key":"2025121408495956000_7.3.e012665.45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-11-469551"},{"key":"2025121408495956000_7.3.e012665.46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1536867X0400400301","article-title":"Multiple imputation of missing values","volume":"4","author":"Royston","year":"2004","journal-title":"Stata J"},{"key":"2025121408495956000_7.3.e012665.47","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.10516"},{"key":"2025121408495956000_7.3.e012665.48","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/bmj.c4245","article-title":"Antipsychotic drugs and risk of venous thromboembolism: nested case-control study","volume":"341","author":"Parker","year":"2010","journal-title":"BMJ"},{"key":"2025121408495956000_7.3.e012665.49","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv098"},{"key":"2025121408495956000_7.3.e012665.50","unstructured":"NHS_England. NHS public health functions agreement 2015\u201316. Service specification no.18. NHS Sickle Cell and Thalassaemia Screening Programme. 10100 PIPP, 2014."},{"key":"2025121408495956000_7.3.e012665.51","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10021"},{"key":"2025121408495956000_7.3.e012665.52","doi-asserted-by":"publisher","DOI":"10.3310\/hta13320"},{"key":"2025121408495956000_7.3.e012665.53","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp08X277276"},{"key":"2025121408495956000_7.3.e012665.54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197302082880612"},{"key":"2025121408495956000_7.3.e012665.55","unstructured":"Dyson S , Boswell G . Sickle cell and deaths in custody. London: Whiting and Birch, 2009."},{"key":"2025121408495956000_7.3.e012665.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2008.09.039"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-012665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:50:08Z","timestamp":1765731008000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-012665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,29]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.1136\/bmjopen-2016-012665"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-012665","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}